SESANA MARIA SILVIA

Amenta, A., Comi, S., Kravicz, M., Sesana, S., Antoniou, A., Passarella, D., et al. (2025). A novel, glutathione-activated prodrug of pimasertib loaded in liposomes for targeted cancer therapy. RSC MEDICINAL CHEMISTRY, 16(1), 168-178 [10.1039/d4md00517a]. Dettaglio

Sica, F., Patrucco, M., Giambra, M., Ghizzi, M., Sesana, S., Vergani, B., et al. (2025). Modulation of the blood–brain barrier permeability by patient-derived glioblastoma stem cell secretome. SCIENTIFIC REPORTS, 15(1) [10.1038/s41598-025-21272-3]. Dettaglio

La Rosa, F., Agostini, S., Bolognesi, E., Marventano, I., Mancuso, R., Guerini, F., et al. (2025). Engineered Glibenclamide-Loaded Nanovectors Hamper Inflammasome Activation in an Ex Vivo Alzheimer’s Disease Model—A Novel Potential Therapy for Neuroinflammation: A Pilot Study. BIOMOLECULES, 15(8) [10.3390/biom15081074]. Dettaglio

Viale, F., Ciprandi, M., Leoni, L., Sierri, G., Renda, A., Barbugian, F., et al. (2024). Biodegradable SPI-based hydrogel for controlled release of nanomedicines: a potential approach against brain tumors recurrence. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 96(June 2024) [10.1016/j.jddst.2024.105672]. Dettaglio

Sierri, G., Patrucco, M., Ferrario, D., Renda, A., Comi, S., Ciprandi, M., et al. (2024). Targeting specific brain districts for advanced nanotherapies: A review from the perspective of precision nanomedicine. WILEY INTERDISCIPLINARY REVIEWS. NANOMEDICINE AND NANOBIOTECHNOLOGY, 16(5 (September/October 2024)) [10.1002/wnan.1991]. Dettaglio